跳至主要内容
临床试验/NCT05413382
NCT05413382已完成不适用

A Randomized, Double-Blind, Crossover, Clinical Study to Investigate the Effect of an Investigational Lozenge (Biofresh® 4plus) Versus Placebo Control on Oral Malodor (Intra-Oral Halitosis)

Novozymes A/S1 个研究点 分布在 1 个国家目标入组 53 人开始时间: 2021年9月28日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Novozymes A/S
入组人数
53
试验地点
1
主要终点
Immediate Total Volatile Sulphur Compounds (T-VSC)

研究概览

简要总结

This study is designed to evaluate the effect of an investigational lozenge with the enzyme polyphenol oxidase and green coffee extract in reducing and controlling intra-oral halitosis following immediate use and daily use of the lozenge over a one-week period.

详细描述

This randomized, placebo controlled, double-blind, crossover study will use gas chromatography (GC) and oral microbial measurements to evaluate the reduction and control of intra-oral halitosis by an investigational lozenge containing the enzyme polyphenol oxidase and green coffee extract compared to a placebo control lozenge. A one-week washout period will precede the first crossover period and a one-week washout period will be implemented between periods 1 and 2. The study will consist of five study visits: Screening Visit, Period 1 Baseline Visit, Crossover Period 1 Day 8 Visit, Period 2 Baseline Visit, Crossover Period 2 Day 8 Visit.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •To be eligible for study participation, subjects must meet the following criteria:
  • •Inclusion criteria:
  • •Generally healthy males and females ≥18 years of age.
  • •Able to read, sign and receive a copy of the signed informed consent form.
  • •Have an average OralChroma™ reading ≥ 125 ppb hydrogen sulfide (H2S gas), volatile sulfur compound (VSC), based on 2 VSC measurements at Screening (Visit 1) and Baseline (Visit each 2 and 4), at least 12 hours after eating or drinking or oral hygiene.
  • •Difference of the hydrogen sulfide gas readings is ≤ 500 ppb following the two mouth air samples for each VSC measurement for Screening (Visit 1) and Baseline (Visits 2 and 4).
  • •Intra-oral cause of bad breath (non-systemic origin) as determined by health history or exam.
  • •Have at least 18 natural teeth.
  • •Agree to abstain from eating, drinking, breath mints, chewing gum, and any oral hygiene for at least 12 hours prior to evaluation of oral malodor at Screening, Baseline and Day 8 visits.
  • •Agree to avoid drinking alcohol beverages and eating spicy foods, garlic and onions, cabbage, spices, cauliflower, and radishes (sulfur compounds) 48 hours prior to each study visit.
  • •Agree to refrain from tongue brushing/cleaning for the duration of the study.
  • •Adequate oral hygiene and no signs of oral neglect.

排除标准

  • •Subjects presenting with any of the following will not be included in the study:
  • •History of allergy or significant adverse effects following use of oral hygiene products such as toothpastes, mouth rinses, breath mints, lozenges, or chewing gum or their ingredients.
  • •History of allergies to ingredients in the test product.
  • •Self-reported as pregnant or nursing.
  • •Self-reported serious medical conditions.
  • •Based on history and clinical exam: advanced and/or untreated periodontitis, frank caries, and mucosal diseases.
  • •Antibiotic or anti-inflammatory medication within 30 days of screening visit.

研究组 & 干预措施

Investigational lozenge

Active Comparator

Lozenge containing the enzyme polyphenol oxidase and green coffee extract

干预措施: Biofresh® 4plus (Dietary Supplement)

Placebo lozenge

Placebo Comparator

Lozenge equal to active comparator but without active ingredients

干预措施: Placebo (Dietary Supplement)

结局指标

主要结局

Immediate Total Volatile Sulphur Compounds (T-VSC)

时间窗: The change in T-VSCs from baseline to 5-minutes post-product assessment

The primary efficacy endpoint is the immediate (no later than 5 minutes after dissolution of the lozenge) T-VSCs at Day 1 based on OralChroma™ measurement.

次要结局

  • Questionnaire(Day 1 and Day 8)
  • T-VSCs over time(The change in T-VSCs over time from baseline to 1 hour, 2 hours, 4 hours (Day 1), and 7 days post-product assessments)
  • Specific VSCs over time(The change in specific VSCs over time from baseline to 1 hour, 2 hours, 4 hours (Day 1), and 7 days post-product assessments)
  • Oral microbiome composition(Day 1 (pre and immediate post-product use, 5 minutes) and Day 8)

研究者

发起方
Novozymes A/S
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验